A

Adimab, LLC

128 employees

Adimab is an antibody discovery and optimization platform, developing full-length human Immunoglobulin Gs.

Investor insights

Sectors invested in

Biotechnology1

Therapeutics1

Pharmaceutical1

Funding rounds participated in

$50M sweet spot round size

Most of their 1 investments are in rounds between $50M and $50M

Basic info

Industry

biotechnology research

Sectors

Biotechnology

rare disease

Health Care

Collaboration

Therapeutics

autoimmune disease

Human antibody discovery

oncology

Date founded

2007

Investments made

A

Adagio Therapeutics raised $50M on July 16, 2020

Investors: OrbiMed Advisors, Polaris Partners, Mithril Capital Management LLC, GV and Adimab, LLC

Funding rounds raised

Total raised

$14M

from 19 investors over 19 rounds

A

Adimab, LLC raised undisclosed on January 1, 2020

Investors: Lux Capital

A

Adimab, LLC raised $14M on April 3, 2012

Investors: SV Life Sciences, Polaris Partners and GV

A

Adimab, LLC raised $8.2M on January 22, 2010

Investors: GV, OrbiMed Advisors, Polaris Partners, Borealis Ventures and SV Life Sciences

A

Adimab, LLC raised $4M on November 20, 2008

Investors: Borealis Ventures, Polaris Partners, SV Life Sciences and OrbiMed Advisors

A

Adimab, LLC raised $3.2M on March 25, 2008

Investors: Polaris Partners and SV Life Sciences

A

Adimab, LLC raised $5.9M on September 21, 2007

Investors: SV Life Sciences and Polaris Partners

A

Adimab, LLC raised $6.2M on July 20, 2007